1 / 39

HEART-LUNG TRANSPLANTATION

This report provides detailed insights into heart-lung transplants in adult recipients, covering diagnoses, survival rates, immunosuppression strategies, post-transplant morbidities, and outcomes up to June 2012.

glloyd
Download Presentation

HEART-LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEART-LUNG TRANSPLANTATION Adult Recipients 2013 JHLT. 2013 Oct; 32(10): 965-978

  2. Donor, Recipient and Center Characteristics 2013 JHLT. 2013 Oct; 32(10): 965-978

  3. Adult Heart-Lung TransplantsDiagnosis (Transplants: January 1982 – June 2012) 2013 NOTE: “Other” includes cancer, LAM, OB, bronchiectasis JHLT. 2013 Oct; 32(10): 965-978

  4. Adult Heart-Lung TransplantsDiagnosis (Transplants: January 1982 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  5. Adult Heart-Lung TransplantsDiagnosis by Era (Transplants: January 1982 – June 2012) 2013 NOTE: “Other” includes OB (non-Re-Tx) and Bronchiectasis. JHLT. 2013 Oct; 32(10): 965-978

  6. Adult Heart-Lung TransplantsMajor Indications by Year (%) 2013 JHLT. 2013 Oct; 32(10): 965-978

  7. Adult Heart-Lung TransplantsMajor Indications By Year (Number) 2013 JHLT. 2013 Oct; 32(10): 965-978

  8. Adult Heart-Lung TransplantsAge Distribution By Location(Transplants: January 2000 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  9. Adult Heart-Lung TransplantsDiagnosis Distribution By Location(Transplants: January 2000 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  10. Adult Heart-Lung TransplantsDonor Age Distribution By Location(Transplants: January 2000 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  11. Post-Transplant: Survival and Other Outcomes 2013 JHLT. 2013 Oct; 32(10): 965-978

  12. Adult Heart-Lung TransplantsKaplan-Meier Survival (Transplants: January 1982 – June 2011) 2013 JHLT. 2013 Oct; 32(10): 965-978

  13. Adult Heart-Lung Transplants Kaplan-Meier Survival by Era (Transplants: January 1982 – June 2011) 2013 JHLT. 2013 Oct; 32(10): 965-978

  14. Adult Heart-Lung TransplantsKaplan-Meier Survival By Diagnosis (Transplants: January 1990 – June 2011) 2013 JHLT. 2013 Oct; 32(10): 965-978

  15. Adult Heart-Lung TransplantsKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year (Transplants: January 1990 – June 2011) 2013 JHLT. 2013 Oct; 32(10): 965-978

  16. Adult Heart-Lung TransplantsFunctional Status of Surviving Recipients (Follow-ups: March 2005 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  17. Adult Heart-Lung TransplantsEmployment Status of Surviving Recipients(Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  18. Adult Heart-Lung TransplantsEmployment Status of Surviving Recipients by Era(Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  19. Adult Heart-Lung TransplantsRehospitalization Post-transplant of Surviving Recipients (Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  20. Induction and Maintenance Immunosuppression 2013 JHLT. 2013 Oct; 32(10): 965-978

  21. Adult Heart-Lung Transplants Induction Immunosuppression(Transplants: January 2001 – June 2012) 2013 Analysis is limited to patients who were alive at the time of the discharge JHLT. 2013 Oct; 32(10): 965-978

  22. Adult Heart-Lung Transplants Induction Immunosuppression(Transplants: January 2000 – December 2011) 2013 Analysis is limited to patients who were alive at the time of the discharge JHLT. 2013 Oct; 32(10): 965-978

  23. Adult Heart-Lung Transplants Induction Immunosuppression(Transplants: January 2000 – December 2011) 2013 Analysis is limited to patients who were alive at the time of the discharge JHLT. 2013 Oct; 32(10): 965-978

  24. Adult Heart-Lung Transplants Maintenance Immunosuppression at Time of Follow-up (Follow-ups: January 2001 – June 2012) NOTE: Different patients are analyzed in Year 1 and Year 5 2013 Analysis is limited to patients who were alive at the time of the follow-up JHLT. 2013 Oct; 32(10): 965-978

  25. Adult Heart-Lung Transplants Maintenance Immunosuppression Drug Combinations at Time of Follow-up (Follow-ups: January 2001 – June 2012) NOTE: Different patients are analyzed in Year 1 and Year 5 2013 Analysis is limited to patients who were alive at the time of the follow-up JHLT. 2013 Oct; 32(10): 965-978

  26. Post-transplant Morbidities 2013 JHLT. 2013 Oct; 32(10): 965-978

  27. Adult Heart-Lung TransplantsCumulative Morbidity Rates in Survivors within 1 and 5 Years Post-Transplant (Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  28. Adult Heart-Lung TransplantsFreedom from Coronary Artery Vasculopathy and Bronchiolitis Obliterans Syndrome(Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  29. Adult Heart-Lung TransplantsFreedom from Coronary Artery Vasculopathy By Diagnosis Type (Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  30. Adult Heart-Lung TransplantsFreedom from Bronchiolitis Obliterans Syndrome By Diagnosis Type(Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  31. Adult Heart-Lung TransplantsFreedom from Severe Renal Dysfunction* (Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  32. Adult Heart-Lung TransplantsPost Transplant Malignancy (Follow-ups: April 1994 – June 2012) Cumulative Morbidity Rates in Survivors * Recipients may have experienced more than one type of malignancy so sum of individual malignancy types may be greater than total number with malignancy. 2013 JHLT. 2013 Oct; 32(10): 965-978

  33. Adult Heart-Lung TransplantsFreedom from Malignancy(Follow-ups: April 1994 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  34. Adult-Heart Lung TransplantsCause of Death (Deaths: January 1992 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  35. Adult Heart-Lung TransplantsRelative Incidence of Leading Causes of Death(Deaths: January 1992 – June 2012) 2013 JHLT. 2013 Oct; 32(10): 965-978

  36. Multivariable Analysis 2013 JHLT. 2013 Oct; 32(10): 965-978

  37. Adult Heart-Lung Transplants (January 1995 – June 2011)Risk Factors For 1 Year Mortality N = 1,681 * Other = All diagnoses other than IPAH and Congenital 2013 JHLT. 2013 Oct; 32(10): 965-978

  38. Adult Heart-Lung Transplants (January 1995 – June 2011)Risk Factors For 1 Year Mortality with 95% Confidence Limits Donor Age p = 0.0195 2013 JHLT. 2013 Oct; 32(10): 965-978

  39. Adult Heart-Lung Transplants (January 1995 – June 2011)Risk Factors For 1 Year Mortality with 95% Confidence Limits Transplant Center Volume p = 0.0519 2013 JHLT. 2013 Oct; 32(10): 965-978

More Related